Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients

被引：0
|
作者：
Nseir, G.
Venetz, J. -P
Hadaya, K.
Buhler, L.
Martin, P-Y
Pascual, M.
机构：
来源：
SWISS MEDICAL WEEKLY | 2008年 / 138卷 / 47-48期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：18S / 18S
页数：1
相关论文
共 50 条
  • [21] IMPROVEMENT IN GLUCOSE REGULATION AND VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN-INHIBITOR TO SIROLIMUS-BASED IMMUNOSUPPRESSION
    Messineo, A.
    Viecelli, A.
    Chan, D.
    Dogra, G.
    Lim, W.
    NEPHROLOGY, 2010, 15 : 60 - 61
  • [22] Proteinuria after Conversion to Sirolimus-Based Immunosuppression in Cardiac Transplant Recipients: A Five Year Analysis
    Raichlin, E.
    Al-Omari, M. A.
    Edwards, B. S.
    Daly, R. C.
    Frntz, R. F. P.
    Clavell, A. C. L.
    Pereira, N. L.
    Schirger, J. A.
    Kushwaha, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S50 - S51
  • [23] Safe conversion to sirolimus for skin cancer in stable renal transplant recipients (RTR)
    Shapiro, R. J.
    Greanya, E. D.
    Argentin, C. P.
    Sun, Y.
    Li, G. Y.
    Partovi, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 523 - 523
  • [24] Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression
    McKenna, G. J.
    Trotter, J. F.
    Klintmalm, E.
    Onaca, N.
    Ruiz, R.
    Jennings, L. W.
    Neri, M.
    O'Leary, J. G.
    Davis, G. L.
    Levy, M. F.
    Goldstein, R. M.
    Klintmalm, G. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2379 - 2387
  • [25] Sirolimus: A Switch Option for Mycophenolate Mofetil-Induced Leukopenia in Renal Transplant Recipients
    Shin, B. C.
    Chung, J. H.
    Kim, H. L.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (08) : 2968 - 2969
  • [26] GLUCOSE METABOLISM FOLLOWING CONVERSION FROM CNI TO SIROLIMUS BASED IMMUNOSUPRESSION IN STABLE RENAL TRANSPLANT RECIPIENTS
    Kamaraj, Kam
    Baboolal, Keshwar
    TRANSPLANT INTERNATIONAL, 2009, 22 : 120 - 120
  • [27] Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients
    Aliabadi, A. Z.
    Pohanka, E.
    Seebacher, G.
    Dunkler, D.
    Kammerstaetter, D.
    Wolner, E.
    Grimm, M.
    Zuckermann, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (04) : 854 - 861
  • [28] Impact of Conversion to Sirolimus-Based Immunosuppression on Fibrosis Progression in HCV plus Liver Transplant Recipients.
    Stevens, D. R.
    Curry, M. P.
    Nandy, N.
    Nasser, I.
    Challies, T.
    Rogers, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [29] SIROLIMUS-BASED IMMUNOSUPPRESION IS ASSOCIATED WITH INCREASED SURVIVAL AFTER LIVER TRANSPLANTATION FOR HEPATO-CELLULAR CARCINOMA
    Toso, C.
    Merani, S.
    Bigam, D.
    Shapiro, J.
    Kneteman, N.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S55 - S55
  • [30] Sirolimus-based immunosuppresion is associated with increased survival after liver transplantation for hepato-cellular carcinoma
    Toso, C.
    Merani, S.
    Bigam, D.
    Shapiro, J.
    Kneteman, N.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 3 - 3
12345